No result left unfinished.

Teleia follows every positive multi-cancer early detection blood test from the moment the result arrives to a documented final answer. It lays out the workup for the predicted cancer site with every step tied to its published source, gives each step an owner and a due date, flags anything that stalls, keeps the patient informed in plain language, and records the answer a clinician signs. It works with any test brand.